Filing Details
- Accession Number:
- 0001140361-14-031053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-06 16:15:46
- Reporting Period:
- 2014-08-06
- Filing Date:
- 2014-08-06
- Accepted Time:
- 2014-08-06 16:15:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581720 | Loxo Oncology Inc. | LOXO | Pharmaceutical Preparations (2834) | 462996673 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612217 | Z. Avi Naider | C/O Loxo Oncology, Inc. One Landmark Square, Suite 1122 Stamford CT 06901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-06 | 76,017 | $0.00 | 151,499 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-08-06 | 3,846 | $13.00 | 155,345 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-08-06 | 62,499 | $0.00 | 62,499 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-08-05 | 13,518 | $0.00 | 13,518 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- In connection with the consummation of the Issuer's initial public offering on August 6, 2014, each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration. All shares of Common Stock issued upon conversion were aggregated.
- None.
Billionaire Hedge Funds
